Drawing for ALCIS

USPTO serial 79424329

ALCIS

Reviewed by CopyMark Law Group

Reg. 8190913Status 700Registered
Filing date
Status date
Registration date
Mar 31, 2026
Examiner
HARMON KENNEDY, HEATHER N
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with ALCIS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

April L. Besl

April L. Besl Dinsmore & Shohl LLP255 East Fifth Street, Suite 1900Cincinnati, OH 45202United States

Goods and services

ClassDescriptionStatusFirst use
001Immunoassay reagents for scientific or research purposes; reagents for use in scientific apparatus for chemical or biological analysis, other than for medical or veterinary purposes; biological sample testing reagents for scientific or research purposes; biological samples, namely, biological tissue cultures for scientific or research purposes; reagents for scientific or medical research use; diagnostic reagents for scientific or research use; in vitro diagnostic reagents for scientific purposesACTIVE—
005Immunoassay reagents for medical use; biological reagents for medical purposes; biological samples, namely, biological tissue cultures for medical or veterinary purposes; reagents for medical use; diagnostic reagents for medical or veterinary purposes; diagnostic test reagents for medical or veterinary purposes; biological sample testing reagents for medical or veterinary purposes; analytical reagents used in medical devices for medical purposes for in vitro diagnostics; reagents for antigen-antibody binding immunoassays for medical purposesACTIVE—
010Cartridges for detecting the presence or concentration of a biological sample for medical use, namely, medical diagnostic instruments for the analysis of body fluids; immunoassay apparatus for medical diagnosis, namely, medical diagnostic apparatus for analyzing biological samples of the body; immunoassay cartridges for medical use, namely, medical devices for use in treating or diagnosing cancer, cardiovascular diseases and diabetes; instruments and devices for testing biological samples for blood sugar levels, cancer cells, and DNA for medical use; cartridges for analyzing biological samples for medical use being medical diagnostic instruments for analyzing and identifying bacteria; automated analysis devices for biological samples for medical use, namely, automated medical diagnostic instruments for the analysis of body fluids; diagnostic measuring apparatus for medical use, namely, medical diagnostic apparatus for detecting biomarkers, pregnancy, and viruses; cartridges for medical purposes, namely, medical apparatus and instruments for monitoring blood gas concentrations; immunoassay cartridges for in vitro diagnostics for medical use being medical diagnostic apparatus for testing DNA and RNA samplesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 1, 2026FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Sep 10, 2026FICSFINAL DISPOSITION NOTICE SENT TO IB—
Sep 10, 2026FIMPFINAL DISPOSITION PROCESSED—
Jun 30, 2026FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Mar 31, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Mar 31, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 10, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 10, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 4, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 15, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 16, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 16, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 16, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 7, 2025RFNTREFUSAL PROCESSED BY IB—
Oct 21, 2025RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Oct 20, 2025RFRRREFUSAL PROCESSED BY MPU—
Sep 5, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Sep 4, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 21, 2025DOCKASSIGNED TO EXAMINER—
May 23, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
May 23, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 22, 2025REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance